14 hedge funds and large institutions have $2.26M invested in BiomX in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 1 closing their positions.

Holders
14
Holders Change
+3
Holders Change %
+27.27%
% of All Funds
0.21%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.01%
New
4
Increased
1
Reduced
3
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
O
1
OrbiMed
New York
$1.26M 4,517,589 -35,900 -0.8%
JJ
2
Johnson & Johnson
New Jersey
$597K 2,133,402
8GI
3
8VC GP I
Texas
$304K 1,086,191 +1,086,191 New
Renaissance Technologies
4
Renaissance Technologies
New York
$31K 110,294 -34,333 -24%
MI
5
MMCAP International
Cayman Islands
$26.3K 96,805 -415,697 -81%
BCM
6
Bridgeway Capital Management
Texas
$13.9K 49,500
Citadel Advisors
7
Citadel Advisors
Florida
$9.4K 33,582 +33,582 New
Walleye Capital
8
Walleye Capital
New York
$5.9K 21,056
XT
9
XTX Topco
Cayman Islands
$4.07K 14,531 +14,531 New
Susquehanna International Group
10
Susquehanna International Group
Pennsylvania
$3.05K 10,908 +10,908 New
Walleye Trading
11
Walleye Trading
New York
$2.92K 10,422
PNC Financial Services Group
12
PNC Financial Services Group
Pennsylvania
$1.12K 4,000
UBS Group
13
UBS Group
Switzerland
$560 2,000 +1,896 +1,823%
Millennium Management
14
Millennium Management
New York
-23,350 Closed
Bank of America
15
Bank of America
North Carolina
$0 1
CFGS
16
Concourse Financial Group Securities
Alabama